Inventor · disambiguated record
Zhaohui Shao
Also filed as: SHAO ZHAOHUI
10 granted patents·9 pending applications·112 citations·filing 2007–2021
89Inventor score
Top patents by PatentIndex Score
19 records- 0196US8128926B2Sp35 antibodies and uses thereofMI SHA·Filed 2009·Granted Mar 6, 2012·29 cites·20 claims
- 0295US9066984B2Sp35 antibodies and uses thereofBIOGEN IDEC INC·Filed 2013·Granted Jun 30, 2015·26 cites·6 claims
- 0395US8551476B2SP35 antibodies and uses thereofMI SHA·Filed 2007·Granted Oct 8, 2013·34 cites·16 claims
- 0490US8609407B2Sp35 antibodies and uses thereofMI SHA·Filed 2012·Granted Dec 17, 2013·6 cites·18 claims
- 0586US9550798B2Compounds that are S1P modulating agents and/or ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Jan 24, 2017·8 cites·25 claims
- 0685US9555050B2ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Jan 31, 2017·4 cites·24 claims
- 0782US9522889B2ATX modulating agentsBIOGEN MA INC·Filed 2013·Granted Dec 20, 2016·5 cites·31 claims
- 0875US2021395360A1SP35 Antibodies And Uses ThereofBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 0971US2020317775A1SP35 Antibodies And Uses ThereofBIOGEN MA INC·Filed 2020·Application pending·0 cites
- 1067US2019161546A1SP35 Antibodies And Uses ThereofBIOGEN MA INC·Filed 2018·Application pending·0 cites
- 1165US2013287796A1Sp35 Antibodies and Uses ThereofBIOGEN IDEC INC·Filed 2013·Application pending·0 cites
- 1262US2017037126A1SP35 Antibodies And Uses ThereofBIOGEN MA INC·Filed 2016·Application pending·0 cites
- 1361US2015315273A1SP35 Antibodies And Uses ThereofBIOGEN MA INC·Filed 2015·Application pending·0 cites
- 1460US2014199315A1Sp35 Antibodies and Uses ThereofBIOGEN IDEC INC·Filed 2013·Application pending·0 cites
- 1556US12472171B2Methods for treating hypercholesterolemiaBIOGEN MA INC·Filed 2021·Granted Nov 18, 2025·0 cites·17 claims
- 1655US2011311542A1Sp35 Antibodies and Uses ThereofMI SHA·Filed 2011·Application pending·0 cites
- 1748US9944666B2Compounds that are S1P modulating agents and/or ATX modulating agentsBIOGEN MA INC·Filed 2016·Granted Apr 17, 2018·0 cites·15 claims
- 1848US2023390270A1Methods for treating remitting multiple sclerosisBIOGEN MA INC·Filed 2021·Application pending·0 cites
- 1947US10017506B2ATX modulating agentsBIOGEN MA INC·Filed 2016·Granted Jul 10, 2018·0 cites·21 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →